Interest in Novel Lymphoma Drug Expands to Two Key Subtypes

(MedPage Today) — HOUSTON — Already indicated for relapsed/refractory follicular lymphoma, the bispecific antibody mosunetuzumab (Lunsumio) showed early promise for improving outcomes in two key lymphoma subtypes, according to studies reported…

Source link : https://www.medpagetoday.com/meetingcoverage/soho/117371

Author :

Publish date : 2025-09-09 14:53:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Interest in Novel Lymphoma Drug Expands to Two Key Subtypes

Emphysema Not Just an Incidental Finding on Lung Cancer Screening CT

Don’t Pin Heart Attacks on Daylight Savings Time, Study Says

Related Posts

How Well Do Mothers Follow Infant Sleep and Care Practices?

Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics

Can a Dementia Drug Help Some Kids With Autism?

RT Matches Catheter Ablation for Refractory Ventricular Tachycardia, and It’s Safer

Study on Medicaid Work Requirements Finds No Gains in Insurance, Employment

‘It’s Better All the Way Around’: Changing How Primary Care Docs Are Paid

How Well Do Mothers Follow Infant Sleep and Care Practices?

Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics

Can a Dementia Drug Help Some Kids With Autism?

RT Matches Catheter Ablation for Refractory Ventricular Tachycardia, and It’s Safer

Study on Medicaid Work Requirements Finds No Gains in Insurance, Employment

Selected Biomarkers Help Detect Early Gestational Diabetes

‘It’s Better All the Way Around’: Changing How Primary Care Docs Are Paid

Pelvic Radiation Cuts Recurrences in High-Risk MIBC

Categories

Archives